French shipping giant CMA CGM agreed to buy 47.6% of port terminal operator Santos Brasil for 6.3 billion reais ($1.2 billion ...
Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...
Neither Gene Seroka nor George Goldman saw evidence that East Coast-bound vessels will be diverted after a possible Oct. 1 ...
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
A threatened Oct. 1 strike by dockworkers at ports on the U.S. East Coast and Gulf of Mexico would immediately disrupt the ...
Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...
Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...
An interdisciplinary research team, including the Faculty of Engineering and Li Ka Shing Faculty of Medicine at The ...
After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...
Veri, which makes a continuous glucose monitor, has announced that it has joined ŌURA, which makes the Oura Ring.
SAO PAULO, Sept 22 (Reuters) - French shipping giant CMA CGM agreed to buy 47.6% of port terminal operator Santos Brasil for 6.3 billion reais ($1.2 billion), and will launch a takeover bid for the ...